We were pleased to participate in this year's #ILADS conference! Dr. Shimasaki presented on "The Emerging Role of CaMKII?: How Tick-Borne and Other Pathogens can active Calmodulin-Dependent Protein Kinase II in Neuronal Cells leading to Chronic Neuropsychiatric Symptoms.

Did you know infections, such as strep, can trigger OCD-like symptoms? Grace was a healthy 5-year-old before a strep infection triggered OCD behaviors, unexplained rages, extreme mood swings and anxiety. https://t.co/zfWqsXcHJ0 #ocdawarenessweek

Today is PANDAS Awareness Day! We're grateful to all the clinicians & researchers who have paved the way for greater understanding of this disorder. We are honored to have helped over 2,500 clinicians & 15,500 patients worldwide identify an underlying autoimmune encephalopathy.

We have partnered with BioSymetrics to develop treatment-predictive algorithms based on outcomes of over 15,000 patients tested with the Autoimmune Brain Panel. https://t.co/oUva4d253P

Dr. Shimasaki discusses the role of infections and immune dysfunction in neuropsychiatric disorders at this year's Mast Cell Masterminds Conference!

We are excited to welcome Dr. Robert Mozayeni to our Medical and Clinical Advisor Board! Dr. Mozayeni is an accomplished physician, researcher, and leader in the fields of infectious disease and immune-mediated responses. https://t.co/jxfyyi3KLB

How do infections impact the immune system and the brain, leading to neurologic and psychiatric symptoms? Join Dr. Craig Shimasaki for a presentation and Q&A session. Register: https://t.co/Pt7zxMNMGG

Patients & Parents: Join Dr. Craig Shimasaki as he discusses the biological process behind autoimmune neuropsychiatric disorders & reviews patient cases. Live Q&A to follow! Register: https://t.co/d3YKwMXdEW

Study finds children with #tic disorders had significantly elevated levels of pro-inflammatory cytokines - IL-1β, TNF-α, IL-6 and IL-4 expression. https://t.co/YwQ5X9bcZP

This study reviews immunomodulating treatments that could be applied for controlling neuroinflammation in patients with #autism spectrum disorder. https://t.co/hWGsRSdgV2

A new study has found that patients diagnosed with schizophrenia or another psychotic disorder are three times more likely to have Bartonella DNA in their blood than adults without these disorders. https://t.co/PZzZ6VuR4j

Webinar recording now available! "Immune Dysfunction & Neuropsychiatric Disorders: The role of CaMKII in the Autoimmune Brain Panel" - you can now access the recording! Thanks to the @AcadOfNutriMed for hosting.

We are excited to welcome Dr. Vijay Aggarwall as Chairman of the Board! Dr. Aggarwall brings decades of experience in pharmaceutical services, diagnostics, and medical devices to the position. https://t.co/KYK80j7MYm

We have entered into a strategic alliance with Quest Diagnostics.

“In this case, the [PANDAS] patient not only did not respond to antibiotic therapy but also failed to respond to conventional psychotherapy with SSRIs. He did, however, respond exceedingly well to antidopaminergic pharmacotherapy.” #PANDAS #treatment https://t.co/4RY7IG9DAB

The Cunningham Panel of tests helps identify autoimmune-induced neuropsychiatric symptoms in a patient initially diagnosed with bipolar disorder. Full report: https://t.co/m3poJyfRLD

Moleculera Labs welcomes Rodney Cotton, former Senior VP, Roche Diagnostics, to its Board of Directors. https://t.co/NMsoUikeiX

IVIG improves multiple neuropsychiatric symptoms in PANS patients “Improvement was primarily seen in memory (58%), sensory-motor (37%) and visual-motor integration (30%).” https://t.co/MJmLtNEVf8

https://t.co/ZkSxeLB8rE

https://t.co/FskGNbdNm7